Disc Medicine IRON Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Returns | |||||
| Return on equity | -35.9%-8.1pp | -27.7%+1.6pp | -29.3%— | —— | |
| Return on invested capital | -49.1%— | —— | —— | —— | |
| Liquidity | |||||
| Current ratio | 21.9×+0.8× | 21.2×+4.1× | 17.1×+8.3× | 8.8×+2.1× | |
| Leverage | |||||
| Debt-to-equity | 0×0.0× | 0.1×+0.1× | 0×0.0× | 0×— | |
| Per Share | |||||
| Book value per share | $20.96+30.4% | $16.07+3.9% | $15.47-90.9% | $169.89+332% | |
| Valuation | |||||
| Market capitalization | $3B+58.9% | $1.89B+38.6% | $1.36B+5,053% | $26.41M-84.2% | |
| Price / book | 4.1×-0.2× | 4.3×+0.3× | 3.9×+3.8× | 0.1×— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Disc Medicine's ratios come from?
- Every ratio is computed from Disc Medicine's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.